Spotlight On Penny Stocks To Consider In May 2026

Organogenesis

Organogenesis

ORGO

0.00

Over the last 7 days, the market has remained flat, but it is up 25% over the past year with earnings forecast to grow by 17% annually. In such a climate, identifying stocks with strong financial foundations can be key to finding value and growth opportunities. Penny stocks, although an older term, remain relevant as they often represent smaller or newer companies that may offer significant potential when backed by solid fundamentals.

Top 10 Penny Stocks In The United States

Name Share Price Market Cap Rewards & Risks
ZJK Industrial (ZJK) $2.80 $177.53M ✅ 3 ⚠️ 2 View Analysis >
WM Technology (MAPS) $0.3756 $67.48M ✅ 2 ⚠️ 5 View Analysis >
LexinFintech Holdings (LX) $2.07 $344.94M ✅ 3 ⚠️ 2 View Analysis >
Tuya (TUYA) $2.25 $1.45B ✅ 4 ⚠️ 1 View Analysis >
Golden Growers Cooperative (GGRO.U) $5.00 $77.45M ✅ 2 ⚠️ 5 View Analysis >
Niagen Bioscience (NAGE) $3.76 $307.27M ✅ 3 ⚠️ 1 View Analysis >
Cricut (CRCT) $3.94 $894.17M ✅ 2 ⚠️ 2 View Analysis >
Village Farms International (VFF) $2.60 $305.15M ✅ 5 ⚠️ 1 View Analysis >
BAB (BABB) $0.951175 $6.84M ✅ 2 ⚠️ 3 View Analysis >
Marine Petroleum Trust (MARP.S) $5.00 $9.93M ✅ 2 ⚠️ 3 View Analysis >

Let's take a closer look at a couple of our picks from the screened companies.

FingerMotion (FNGR)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: FingerMotion, Inc. is a mobile data specialist company offering mobile payment and recharge platform systems in China, with a market cap of $49.64 million.

Operations: The company generates revenue from its Wireless Communications Services segment, totaling $33.14 million.

Market Cap: $49.64M

FingerMotion, Inc., with a market cap of US$49.64 million, operates in the mobile data sector and has generated US$33.14 million from its Wireless Communications Services segment. Despite being unprofitable and having increased losses over the past five years, it maintains a satisfactory net debt to equity ratio of 2.2%. Recent capital raises through private placements have bolstered its financial position, though volatility remains high with a weekly rate of 14%. The company's short-term assets exceed both short-term and long-term liabilities, indicating some financial stability amidst ongoing challenges.

    FNGR Revenue & Expenses Breakdown as at May 2026
    FNGR Revenue & Expenses Breakdown as at May 2026

    Organogenesis Holdings (ORGO)

    Simply Wall St Financial Health Rating: ★★★★★★

    Overview: Organogenesis Holdings Inc. is a regenerative medicine company that develops, manufactures, and commercializes products for advanced wound care and surgical and sports medicine markets in the United States, with a market cap of $310.11 million.

    Operations: The company's revenue from its regenerative medicine segment totals $514.70 million.

    Market Cap: $310.11M

    Organogenesis Holdings Inc., with a market cap of US$310.11 million, is navigating challenges typical for penny stocks. Despite being unprofitable and not expected to achieve profitability within three years, the company maintains a solid financial position with short-term assets of US$268.5 million exceeding both its short-term and long-term liabilities. The recent decline in quarterly revenue to US$37.23 million from US$86.69 million highlights ongoing volatility, yet the company's debt-free status and sufficient cash runway offer some stability. Recent advancements include completing a Biologics License Application for ReNu, targeting knee osteoarthritis treatment, potentially expanding its market presence if approved by the FDA.

      ORGO Financial Position Analysis as at May 2026
      ORGO Financial Position Analysis as at May 2026

      SES AI (SES)

      Simply Wall St Financial Health Rating: ★★★★★★

      Overview: SES AI Corporation focuses on developing and producing AI-enhanced lithium metal and lithium-ion rechargeable battery technologies for various applications, including electric vehicles and drones, with a market cap of approximately $369.28 million.

      Operations: The company's revenue is primarily derived from its Batteries / Battery Systems segment, amounting to $21.92 million.

      Market Cap: $369.28M

      SES AI Corporation, with a market cap of US$369.28 million, is navigating complexities typical for penny stocks. The company reported first-quarter revenue of US$6.71 million but remains unprofitable with a net loss of US$12.1 million. Despite this, SES AI has more cash than debt and covers its short-term liabilities comfortably with assets totaling US$200.6 million. Recent legal challenges include a class action lawsuit alleging misleading business prospects and overstated growth potential, which could impact investor confidence. The appointment of a new CFO may signal strategic shifts as the company aims to stabilize its financial trajectory amidst volatility concerns.

        SES Debt to Equity History and Analysis as at May 2026
        SES Debt to Equity History and Analysis as at May 2026

        Taking Advantage

        • Explore the 357 names from our US Penny Stocks screener here.
        • Interested In Other Possibilities? Find companies with promising cash flow potential yet trading below their fair value.

        This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.